View Item 

Show simple item record

PEPT2-Mediated Uptake of Neuropeptides in Rat Choroid Plexus
dc.contributor.authorTeuscher, Nathan S.en_US
dc.contributor.authorSmith, David E.en_US
dc.contributor.authorKeep, Richard F.en_US
dc.date.accessioned2006-09-08T19:18:36Z
dc.date.available2006-09-08T19:18:36Z
dc.date.issued2001-06en_US
dc.identifier.citationTeuscher, Nathan S.; Keep, Richard F.; Smith, David E.; (2001). "PEPT2-Mediated Uptake of Neuropeptides in Rat Choroid Plexus." Pharmaceutical Research 18(6): 807-813. <http://hdl.handle.net/2027.42/41485>en_US
dc.identifier.issn0724-8741en_US
dc.identifier.issn1573-904Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/41485
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11474785&dopt=citationen_US
dc.description.abstractPurpose . The peptide transporter PEPT2 was recently shown to be functionally active in rat choroid plexus, suggesting that it may play a role in neuropeptide homeostasis in the cerebrospinal fluid. This study, therefore, examined the role of PEPT2 in mediating neuropeptide uptake into choroid plexus.en_US
dc.format.extent192069 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherNeuropeptidesen_US
dc.subject.otherBiomedical Engineeringen_US
dc.subject.otherChoroid Plexusen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherPEPT2en_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherCarnosineen_US
dc.subject.otherMedical Lawen_US
dc.subject.otherPharmacyen_US
dc.subject.otherGlySaren_US
dc.titlePEPT2-Mediated Uptake of Neuropeptides in Rat Choroid Plexusen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Surgery (Neurosurgery) and Physiology, The University of Michigan, Ann Arbor, Michigan, 48109en_US
dc.contributor.affiliationumCollege of Pharmacy and Upjohn Center for Clinical Pharmacology, The University of Michigan, Ann Arbor, Michigan, 48109en_US
dc.contributor.affiliationumCollege of Pharmacy and Upjohn Center for Clinical Pharmacology, The University of Michigan, Ann Arbor, Michigan, 48109en_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid11474785en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/41485/1/11095_2004_Article_302748.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1023/A:1011088413043en_US
dc.identifier.sourcePharmaceutical Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
11095_2004_Article_302748.pdf
Size:
187.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.